↓ Skip to main content

Utilisation of antithrombotic therapy for stroke prevention in atrial fibrillation in a Sydney hospital: then and now

Overview of attention for article published in International Journal of Clinical Pharmacy, December 2011
Altmetric Badge

Citations

dimensions_citation
16 Dimensions

Readers on

mendeley
25 Mendeley
Title
Utilisation of antithrombotic therapy for stroke prevention in atrial fibrillation in a Sydney hospital: then and now
Published in
International Journal of Clinical Pharmacy, December 2011
DOI 10.1007/s11096-011-9594-y
Pubmed ID
Authors

Beata V. Bajorek, Shu Ren

Abstract

Evidence from pivotal clinical trials conducted more than a decade ago supports the use of antithrombotic therapy, particularly warfarin, for stroke prevention in atrial fibrillation (AF). Despite the wide dissemination of this evidence since that time, there is anecdotal evidence that utilisation of therapy remains suboptimal, especially in the target elderly population, which is reflected in the development of practice tools such as the TAG Clinical Indicator ('Antithrombotics in AF' Indicator 1.6, 2007). Therefore, the objective of this study was to determine the current utilisation of antithrombotic therapy for elderly patients with AF in the local setting, and to compare this utilisation with the results of a prior audit (AUDIT 1), as well as against the recommendations of the TAG Clinical Indicator (TAG IND).

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 25 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Iran, Islamic Republic of 1 4%
United States 1 4%
Slovenia 1 4%
Unknown 22 88%

Demographic breakdown

Readers by professional status Count As %
Researcher 6 24%
Student > Ph. D. Student 5 20%
Student > Bachelor 3 12%
Student > Doctoral Student 2 8%
Other 2 8%
Other 4 16%
Unknown 3 12%
Readers by discipline Count As %
Medicine and Dentistry 15 60%
Pharmacology, Toxicology and Pharmaceutical Science 2 8%
Biochemistry, Genetics and Molecular Biology 2 8%
Nursing and Health Professions 1 4%
Environmental Science 1 4%
Other 0 0%
Unknown 4 16%